News and Events

Congratulations to all of the 2022 PharmD graduates! We are so proud to have worked with so many of you and are thankful for your contributions to CODR during your time with us. We wish you all the best in your next steps!
Peter Addo
Joseph Ahenkorah
Bridget Curtin
Kelly DeBoom
Abby Hauser
Natalie Prak 
Kelly Showel
Cover of Journal of Molecular Medicine

Dr. Reena Kartha, ECP faculty, and Jae Roh, postdoctoral fellow, recently published a review article highlighting oxidative stress and mitochondrial dysfunction as key pathological processes in Gaucher disease.

AAPS graduate research spotlight document

ECP graduate student Siddhee Sahasrabudhe was recently featured in the American Association of Pharmaceutical Scientists (AAPS) Graduate REsearch Spotlight. Sahasrabudhe's research focuses on pharmacometrics. Congratulations! 

Chenwei Yan, undergraduate student and CODR volunteer, was recently recognized by the President of the University of Minnesota with a President’s Student Leadership and Service Award (PSLSA). These awards honor outstanding students for their invaluable leadership and service to the University of Minnesota Twin Cities and the community.

Former CODR graduate student Abhi Sathe was recently promoted to Senior Clinical Pharmacologist at Gilead Sciences. He was mentored by Drs. Cloyd and Coles during his time with CODR and credits the training he received as a key part of his professional success. Congratulations Dr. Sathe!

Congratulations to the CODR faculty and staff who were recognized at the College of Pharmacy's Awards & Recognition Program on 1/11/2022!

  • Jim Cloyd - Special Merit Faculty Research Award; Special Merit Faculty Teaching and Mentoring Award; 45 Years of Service Recognition
  • Lori Endsley - Meritorious Service Award
  • Reena Kartha -  Special Merit Faculty Research Award; Above and Beyond Award

As part of her being named a Rare Disease Difference Maker, Dr. Reena Kartha was interviewed by Engage Health. She shared her path to the rare disease field and more about her innovative undergraduate course which was a huge factor to her being nominated.

CODR’s commercial partner, Allaysis, has submitted a New Drug Application (NDA) to the FDA for an intravenous baclofen product. If there are no hitches in the review process, the product will be available for marketing in late 2022. The development of this product, which is an orphan drug, has provided important financial support for CODR in the form of graduate student stipends and multiple published peer-reviewed papers.

The National Organization for Rare Disorders (NORD) has selected the University of Minnesota and 30 others to become designated as Rare Disease Centers of Excellence